HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY

Size: px
Start display at page:

Download "HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY"

Transcription

1 Virtus Diagnostics Preconception Screen What diseases does it screen your carrier status for? Disease HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY ACIDURIA, TYPE III 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY TYPE II 3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY 3-METHYLGLUTACONIC ACIDURIA, TYPE I 3-METHYLGLUTACONIC ACIDURIA, TYPE V ABCD SYNDROME ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME ACHONDROGENESIS, TYPE IB ACG1B ACYL-CoA DEHYDROGENASE, LONG-CHAIN, DEFICIENCY OF ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY ADRENOLEUKODYSTROPHY ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM AGAMMAGLOBULINEMIA, X-LINKED AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY ACCPN AICARDI-GOUTIERES SYNDROME 1 AICARDI-GOUTIERES SYNDROME 2 AICARDI-GOUTIERES SYNDROME 3 AICARDI-GOUTIERES SYNDROME 4 AICARDI-GOUTIERES SYNDROME 5 ALLAN-HERNDON-DUDLEY SYNDROME AHDS ALPERS DIFFUSE DEGENERATION OF CEREBRAL GRAY MATTER WITH HEPATIC CIRRHOSIS ALPHA THALASSEMIA ALPHA-METHYLACETOACETIC ACIDURIA ALPORT SYNDROME, AUTOSOMAL RECESSIVE ALPORT SYNDROME, AUTOSOMAL RECESSIVE ALPORT SYNDROME, X-LINKED ALSTROM SYNDROME AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL AMISH INFANTILE EPILEPSY SYNDROME ANAUXETIC DYSPLASIA ANHYDROTIC ECTODERMAL DYSPLASIA, IMMUNODEFICIENCY, OSTEOPETROSIS, LYMPHEDEMA OLEDAID Symbol HSD17B3 OPA3 HSD3B2 HMGCL HADH AUH DNAJC19 EDNRB AAAS SLC26A2 ACADL ACADM ACADVL CYP21A2 ABCD1 PEX1 PEX10 PEX13 PEX26 PEX5 BTK SLC12A6 TREX1 RNASEH2B RNASEH2C RNASEH2A SAMDH1 SLC16A2 POLG HBA1 ACAT1 COL4A3 COL4A4 Col4A5 ALMS1 MPL ST3GAL5 RMRP IKBKG

2 ANTIBODY DEFICIENCY DUE TO ICOS DEFECT ANTLEY-BIXLER SYNDROME ARGININOSUCCINIC ACIDURIA AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2 ARTS SYNDROME ASPHYXIATING THORACIC DYSTROPHY 2 ASPHYXIATING THORACIC DYSTROPHY 3 ATAXIA, EARLY-ONSET, WITH oculomotor apraxia AND HYPOALBUMINEMIA ATAXIA-TELANGIECTASIA ATELOSTEOGENESIS, TYPE II a-thalassemia/mental RETARDATION SYNDROME,NONDELETION TYPE, X-LINKED ATYPICAL MYCOBACTERIOSIS, FAMILIAL ATYPICAL MYCOBACTERIOSIS, FAMILIAL ATYPICAL MYCOBACTERIOSIS, FAMILIAL ATYPICAL MYCOBACTERIOSIS, FAMILIAL ATYPICAL MYCOBACTERIOSIS, FAMILIAL ATYPICAL MYCOBACTERIOSIS, FAMILIAL ATYPICAL MYCOBACTERIOSIS, FAMILIAL AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE I Autosomal mental retardation Autosomal mental retardation Autosomal mental retardation CDG 1Q BARTH SYNDROME BARTTER SYNDROME, ANTENATAL, TYPE 1 BARTTER SYNDROME, ANTENATAL, TYPE 2 BETA-HYDROXYISOBUTYRYL CoA DEACYLASE, DEFICIENCY OF BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4 BIOTINIDASE DEFICIENCY BLOOM SYNDROME BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE BRITTLE CORNEA SYNDROME (Ehlers-Danlos syndrome type VIB) CANAVAN DISEASE CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE CARDIOMYOPATHY, DILATED, 3A CARNITINE DEFICIENCY, SYSTEMIC PRIMARY CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET ICOS POR ASL DDC ENPP1 VPS33B VIPAR PRPS1 IFT80 DYNC2H1 APTX ATM SLC26A2 ATRX IFNGR1 IFNGR2 IKBKG IL12B IL12RB1 STAT1 TYK2 AIRE NSUN2 ST3GAL3 SRD5A3 TAZ SLC12A1 KCNJ1 HIBCH AMACR BTD BLM BCKDHB ZNF469 ASPA CPS1 SCO2 TAZ SLC22A5 CPT1A CPT2 CPT2

3 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY CARPENTER SYNDROME CARTILAGE-HAIR HYPOPLASIA CEREBELLAR HYPOPLASIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA CEREBROOCULOFACIOSKELETAL SYNDROME 1 CEREBROTENDINOUS XANTHOMATOSIS CEROID LIPOFUSCINOSIS, NEURONAL, 10 CEROID LIPOFUSCINOSIS, NEURONAL, 6 CEROID LIPOFUSCINOSIS, NEURONAL, 7 CEROID LIPOFUSCINOSIS, NEURONAL, 8 CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT CHARCOT-MARIE-TOOTH DISEASE TYPE 4A CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H CHEDIAK HIGASHI SYNDROME CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2 CHONDRODYSPLASIA, BLOMSTRAND TYPE CITRULLINEMIA, CLASSIC COCKAYNE SYNDROME TYPE B COCKAYNE SYNDROME, TYPE A COENZYME Q10 DEFICIENCY COENZYME Q10 DEFICIENCY COENZYME Q10 DEFICIENCY COENZYME Q10 DEFICIENCY COENZYME Q10 DEFICIENCY COENZYME Q10 DEFICIENCY COFFIN-LOWRY SYNDROME CLS COHEN SYNDROME COMBINED IMMUNODEFICIENCY, X-LINKED COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5 COMBINED SAPOSIN DEFICIENCY CPT2 SLC25A20 RAB23 RMRP VLDLR SNAP29 ERCC6 CYP27A1 CTSD CLN6 MFSD8 CLN8 CLN8 GDAP1 FGD4 LYST ABCB4 ATP8B1 ABCB11 PTH1R ASS1 ERCC6 ERCC8 PDSS2 APTX CABC1 COQ2 COQ9 PDSS1 RPS6KA3 VPS13B IL2RG GFM1 MRPS16 TSFM TUFM MRPS22 PSAP NDUFA7 NDUFA1

4 Complex IV deficiency Complex IV deficiency Complex IV deficiency Complex IV deficiency Complex IV deficiency Complex IV deficiency CONGENITAL ADRENAL HYPERPLASIA CONGENITAL ADRENAL HYPERPLASIA CONGENITAL ADRENAL HYPOPLASIA CONGENITAL DEAFNESS WITH KERATOPACHYDERMIA & CONSTRICTIONS OF FINGERS & TOES CONGENITAL DISORDER OF GLYCOSYLATIO, TYPE IIa CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ia CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ic CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ig CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ii CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIb CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIc CONGENITAL DISORDER OF GLYCOSYLATION TYPE IId CONGENITAL DISORDER OF GLYCOSYLATION TYPE Iig CONGENITAL DISORDER OF GLYCOSYLATION TYPE Iih CONGENITAL DISORDER OF GLYCOSYLATION TYPE Im CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iie CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iif CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In NDUFAF2 NDUFAF4 NDUFS3 NDUFS4 NDUFS5 NDUFS6 NDUFS7 NDUFS8 NDUFV1 COX10 COX15 COX6B1 FASTKD2 sco1 sco2 CYP11B1 CYP17A1 NR0B1 GJB2 MGAT2 PMM2 ALG6 ALG12 ALG2 MOGS SLC35C1 B4GALT1 COG1 COG8 DOLK MPI ALG3 DPM1 MPDU1 ALG8 COG7 SLC35A1 DPAGT1 ALG1 ALG9 RFT1

5 CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY CRANIOFRONTONASAL SYNDROME CREATINE DEFICIENCY SYNDROME, X-LINKED CRISPONI SYNDROME CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE I CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE I CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE II CYSTIC FIBROSIS CYSTINOSIS, ADULT NONNEPHROPATHIC CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE CYSTINOSIS, NEPHROPATHIC D-BIFUNCTIONAL PROTEIN DEFICIENCY DE SANCTIS-CACCHIONE SYNDROME DE SANCTIS-CACCHIONE SYNDROME DEFICIENCY OF ACYL-CoA DEHYDROGENASE FAMILY MEMBER 9 DEFICIENCY OF INTERLEUKIN 1 RECEPTOR ANTAGONIST DENT DISEASE 1 DESMOSTEROLOSIS DIARRHEA 4, MALABSORPTIVE, CONGENITAL DIASTROPHIC DYSPLASIA DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY DIHYDROPYRIMIDINE DEHYDROGENASE DISORDERED STEROIDOGENESIS DONNAI-BARROW SYNDROME DONOHUE SYNDROME DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY ECTODERMAL DYSPLASIA, HYPOHIDROTIC, X-LINKED ELEJALDE DISEASE ELLIS-VAN CREVELD SYNDROME ELLIS-VAN CREVELD SYNDROME; EVC ENCEPHALOPATHY, ETHYLMALONIC EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE SLC4A11 ARX L1CAM HSD11B2 EFNB1 SLC6A8 CRLF1 EFEMP2 FBLN5 ATP6V0A2 CFTR CTNS CTNS CTNS HSD17B4 ERCC6 XPA ACAD9 IL1RN CLCN5 DHCR24 NEUROG3 SLC26A2 DLD DPYD POR LRP2 INSR HSPG2 IKBKG EDA MYO5A EVC2 EVC ETHE1 COL7A1 ITGA6 ITGB4 PLEC1 LAMA3 LAMB3 LAMC2

6 EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION EPILEPSY, PYRIDOXINE-DEPENDENT; EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS FABRY DISEASE FACIOGENITAL DYSPLASIA FAMILIAL MEDITERRANEAN FEVER Fanconi anemia type C FETAL AKINESIA DEFORMATION SEQUENCE FIBROMATOSIS, JUVENILE HYALINE FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND FRASER SYNDROME FRASER SYNDROME FRUCTOSE INTOLERANCE, HEREDITARY FUCOSIDOSIS FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY FUMARASE DEFICIENCY GALACTOKINASE DEFICIENCY GALACTOSEMIA GAUCHER DISEASE GELEOPHYSIC DYSPLASIA GLUCOSE-6-PHOSPHATE DEHYDROGENASE GLUTARIC ACIDEMIA I GLUTATHIONE SYNTHETASE DEFICIENCY GLYCINE ENCEPHALOPATHY GLYCINE ENCEPHALOPATHY GLYCINE ENCEPHALOPATHY GLYCOGEN STORAGE DISEASE I VON GIERKE DISEASE GLYCOGEN STORAGE DISEASE Ib GLYCOGEN STORAGE DISEASE Ic GLYCOGEN STORAGE DISEASE II (pompe) GLYCOGEN STORAGE DISEASE III GLYCOGEN STORAGE DISEASE IV GM1-GANGLIOSIDOSIS TYPE II GM1-GANGLIOSIDOSIS, TYPE I COL17A1 ITGB4 LAMA3 LAMB3 LAMC2 DSP PCDH19 ALDH7A1 ARX SLC25A22 EIF2AK3 GLA FGD1 MEFV FANCC RAPSN ANTXR2 WNT7A FRAS1 FREM2 ALDOB FUCA1 FKTN FH GALK1 GALT GBA ADAMTSL2 G6PD GCDH GSS AMT GCSH GLDC G6PC3 SLC37A4 SLC37A4 GAA AGL GBE1 GLB1 GLB1

7 GONADAL DYSGENESIS WITH ADRENAL FAILURE GRACILE SYNDROME GRISCELLI SYNDROME, TYPE 1 GRISCELLI SYNDROME, TYPE 2 GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY HEMOCHROMATOSIS, JUVENILE, TYPE 2A HEMOCHROMATOSIS, JUVENILE, TYPE 2B HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5 HEMOPHILIA A; HEMA HEMOPHILIA B; HEMB HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY VODI Hermansky Pudlak Syndrome, 9 HERMANSKY-PUDLAK SYNDROME 2 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2 HETEROTAXY, VISCERAL, 1, X-LINKED HOLOCARBOXYLASE SYNTHETASE DEFICIENCY HOMOCYSTINURIA HONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE HOYERAAL-HREIDARSSON SYNDROME HURLER SYNDROME HYALINOSIS, INFANTILE SYSTEMIC HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE DEF. HYPEREKPLEXIA AND EPILEPSY HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1 HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS CMT3, HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS CMT3, HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS CMT3, HYPOGONADOTROPIC HYPOGONADISM HYPOMAGNESEMIA, RENAL, WITH OCULAR INVOLVEMENT HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME HYPOPHOSPHATASIA, CHILDHOOD HYPOPHOSPHATEMIC osteopenia, AUTOSOMAL RECESSIVE NR5A1 BCS1L MYO5A RAB27A GAMT HJV HAMP PRF1 UNC13D STX11 STXBP2 F8 F9 SP110 PLDN AP3B1 UNC93B1 TLR3 ZIC3 HLCS CBS ARSE DKC1 IDUA ANTXR2 L1CAM LBR HADHA ARHGEF9 DOCK8 ABCC8 SLC25A15 PMP22 EGR2 MPZ PRX GNRHR CLDN19 TBCE ALPL DMP1

8 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4 ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE ICHTHYOSIS FOLLICULARIS, ATRICHIA, AND PHOTOPHOBIA SYNDROME ICHTHYOSIS, LAMELLAR, 1 ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 1 ORAI1 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2 STIM1 IMMUNODEFICIENCY DUE TO DEFECT IN CD3-EPSILON IMMUNODEFICIENCY DUE TO DEFECT IN CD3-GAMMA IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1 IMMUNODEFICIENCY, COMMON VARIABLE, 3 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED INFANTILE NEUROAXONAL DYSTROPHY INFANTILE SIALIC ACID STORAGE DISORDER INFANTILE-ONSET SPINOCEREBELLAR ATAXIA INFERTILE MALE SYNDROME INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS ISOVALERIC ACIDEMIA JOHANSON-BLIZZARD SYNDROME JOUBERT SYNDROME 3 JOUBERT SYNDROME 4 JOUBERT SYNDROME 5 JOUBERT SYNDROME 6 JUVENILE AMYOTROPHIC LATERAL SCLEROSIS 2 KRABBE DISEASE LACTIC ACIDOSIS, FATAL INFANTILE (mtdna depletion) LARYNGOONYCHOCUTANEOUS SYNDROME LATHOSTEROLOSIS LEIGH SYNDROME LEIGH SYNDROME, FRENCH-CANADIAN TYPE LEIGH SYNDROME, X-LINKED LESCH-NYHAN SYNDROME LETHAL CONGENITAL CONTRACTURE SYNDROME 1 LETHAL CONGENITAL CONTRACTURE SYNDROME 2 LEUKOCYTE ADHESION DEFICIENCY TYPE III LEUKODYSTROPHY, HYPOMYELINATING, 2 LEUKODYSTROPHY, HYPOMYELINATING, 5 LIPOID CONGENITAL ADRENAL HYPERPLASIA TSHB MBTPS2 TGM1 CLDN1 ORAI1 STIM1 CD3E CD3G CD3Z CD40LG CD19 DNMT3B FOXP3 PLA2G6 SLC17A5 C10ORF2 AR NTRK1 IVD UBR1 AHI1 NPHP1 CEP290 TMEM67 ALS2 GALC SUCLG1 LAMA3 SC5DL SURF1 LRPPRC PDHA1 HPRT1 GLE1 ERBB3 FERMT3 GJC2 FAM126A CYP11A1

9 LIPOID CONGENITAL ADRENAL HYPERPLASIA LISSENCEPHALY 2 LISSENCEPHALY 3 LISSENCEPHALY, X-LINKED, 1 LISSENCEPHALY, X-LINKED, 2 LOWE OCULOCEREBRORENAL SYNDROME LUJAN-FRYNS SYNDROME LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1 LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2 MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY MANNOSIDOSIS, ALPHA B, LYSOSOMAL MAPLE SYRUP URINE DISEASE Type Ia Marinesco-Sjogren Syndrome MARTSOLF SYNDROME MASA SYNDROME MECKEL SYNDROME TYPE 1 MECKEL SYNDROME, TYPE 5 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS MENKES DISEASE MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA CASK MENTAL RETARDATION AUTOSOMAL RECESSIVE 13 MENTAL RETARDATION AUTOSOMAL RECESSIVE 6 MENTAL RETARDATION AUTOSOMAL RECESSIVE 7 MENTAL RETARDATION X-LINKED 19 INCLUDED MENTAL RETARDATION X-LINKED 72 MENTAL RETARDATION X-LINKED 88 MENTAL RETARDATION X-LINKED 89 MENTAL RETARDATION X-LINKED 90 MENTAL RETARDATION X-LINKED 92 MENTAL RETARDATION X-LINKED ASSOCIATED WITH FRAGILE SITE MENTAL RETARDATION X-LINKED SYNDROMIC TURNER TYPE MENTAL RETARDATION X-LINKED SYNDROMIC UBE2A-RELATED MENTAL RETARDATION X-LINKED SYNDROMIC ZDHHC9-RELATED MENTAL RETARDATION X-LINKED SYP-RELATED MENTAL RETARDATION X-LINKED WITH BRACHYDACTYLY AND MACROGLOSSIA MENTAL RETARDATION X-LINKED ZNF711-RELATED MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1 MENTAL RETARDATION, X-LINKED 21 MENTAL RETARDATION, X-LINKED 30 MENTAL RETARDATION, X-LINKED 41, 48 MRX41, STAR RELN TUBA1a DCX ARX OCRL MED12 SH2D1A XIAP ZMPSTE24 MAN2B1 BCKDHA SIL1 GAP2 L1CAM MKS1 RPGRIP1L MLC1 ATP7A CASK TRAPPC9 GRIK2 TUSC3 RPS6KA3 RAB39B AGTR2 ZNF41 DLG3 ZNF674 AFF2 HUWE1 UBE2A ZDHHC9 SYP CUL4B ZNF711 PRSS12 IL1RAPL1 PAK3 GDI1

10 MENTAL RETARDATION, X-LINKED 46 MENTAL RETARDATION, X-LINKED 59 MENTAL RETARDATION, X-LINKED 68 MENTAL RETARDATION, X-LINKED 9 MENTAL RETARDATION, X-LINKED 93 MENTAL RETARDATION, X-LINKED ANGELMAN, SYNDROMIC, CHRISTIANSON MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE MENTAL RETARDATION, X-LINKED, SYNDROMIC MENTAL RETARDATION, X-LINKED, SYNDROMIC 10 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM MENTAL RETARDATION, XLR, W CEREBELLAR HYPOPLASIA & DISTINCTIVE FACIAL APPEARANCE METACHROMATIC LEUKODYSTROPHY METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblc TYPE METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY METHYLMALONIC ACIDURIA, cbla TYPE METHYLMALONIC ACIDURIA, cblb TYPE MEVALONIC ACIDURIA MICROPHTHALMIA, SYNDROMIC MICROPHTHALMIA, SYNDROMIC 9 (Matthew-Wood syndrome) MITOCHONDRIAL COMPLEX III DEFICIENCY MITOCHONDRIAL COMPLEX III DEFICIENCY MITOCHONDRIAL COMPLEX III DEFICIENCY MITOCHONDRIAL DNA DEPLETION SYNDROME, HEPATOCEREBRAL FORM MITOCHONDRIAL DNA DEPLETION SYNDROME, HEPATOCEREBRAL FORM MITOCHONDRIAL DNA DEPLETION SYNDROME, HEPATOCEREBRAL FORM MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME MOLYBDENUM COFACTOR DEFICIENCY MOLYBDENUM COFACTOR DEFICIENCY MSUD type 2 mtdna depletion, encephalomyopathic form mtdna depletion, encephalomyopathic form MUCOLIPIDOSIS II ALPHA/BETA MUCOLIPIDOSIS III ALPHA/BETA MUCOLIPIDOSIS IV MUCOPOLYSACCHARIDOSIS TYPE II MUCOPOLYSACCHARIDOSIS TYPE IIIA (Sanfilippo type A) MUCOPOLYSACCHARIDOSIS TYPE IIIC (Sanfilippo type c) ARHGEF6 AP1S2 ACSL4 FTSJ1 BRWD3 SLC9A6 SMS KDM5C HSD17B10 UPF3B sox3 sox3 OPHN1 ARSA PSAP MMACHC MUT MMAA MMAB MVK BCOR STRA6 BCS1L UQCRB UQCRQ C10ORF2 DGUOK MPV17 TK2 TYMP MOCS2 MOCS1 DBT RRM2B SUCLA2 GNPTAB GNPTAB MCOLN1 IDS SGSH HGSNAT

11 MUCOPOLYSACCHARIDOSIS TYPE VI MAROTEAUX-LAMY MUCOPOLYSACCHARIDOSIS TYPE VII SLY SYNDROME MULIBREY NANISM MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE MUSCLE-EYE-BRAIN DISEASE MUSCLE-EYE-BRAIN DISEASE MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A MUSCULAR DYSTROPHY, CONGENITAL, 1C MUSCULAR DYSTROPHY, CONGENITAL, TYPE 1D MUSCULAR DYSTROPHY, DUCHENNE TYPE MYD88 DEFICIENCY MYOCLONIC EPILEPSY OF LAFORA MYOCLONIC EPILEPSY OF LAFORA MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG MYOTUBULAR MYOPATHY 1 N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY NANCE-HORAN SYNDROME; NAVAJO NEUROHEPATOPATHY NEMALINE MYOPATHY 2 NEPHRONOPHTHISIS 1 NEPHRONOPHTHISIS 2 NEPHRONOPHTHISIS 4 NEPHROSIS 1, CONGENITAL, FINNISH TYPE nephrotic syndrome, STEROID-RESISTANT, AUTOSOMAL RECESSIVE nephrotic syndrome, TYPE 3 NEURAMINIDASE DEFICIENCY NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1 (Hallervorden-Spatz) NEURONAL CEROID LIPOFUSCINOSIS 1 NEURONAL CEROID LIPOFUSCINOSIS 2 NEURONAL CEROID LIPOFUSCINOSIS 3 NEURONAL CEROID LIPOFUSCINOSIS 5 NEUROPATHY, CONGENITAL HYPOMYELINATING: CHARCOT-MARIE-TOOTH DISEASE, TYPE NEUROPATHY, CONGENITAL HYPOMYELINATING: CHARCOT-MARIE-TOOTH DISEASE, TYPE ARSB GUSB TRIM37 ETFA ETFB ETFDH CHRNG CHRNA1 CHRND CHRNG FKRP POMGNT1 LAMA2 FKRP LARGE DMD MYD88D EPM2A NHLRC1 CSTB MTM1 NAGS NHS MPV17 NEB NPHP1 INVS NPHP4 NPHS1 NPHS2 PLCE1 NEU1 FOLR1 PANK2 PPT1 TPP1 CLN3 CLN5 EGR2 MPZ

12 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III NEUTROPENIA, SEVERE CONGENITAL, AUTOSOMAL RECESSIVE 3 NEVO SYNDROME EDS NIEMANN-PICK DISEASE, TYPE NIEMANN-PICK DISEASE, TYPE A NIEMANN-PICK DISEASE, TYPE B NIEMANN-PICK DISEASE, TYPE C1 NIJMEGEN BREAKAGE SYNDROME NORRIE DISEASE ODONTOONYCHODERMAL DYSPLASIA OMENN SYNDROME OMENN SYNDROME OMENN SYNDROME OPITZ GBBB SYNDROME, X-LINKED OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO OSTEOGENESIS IMPERFECTA, TYPE IIB OSTEOGENESIS IMPERFECTA, TYPE VIII OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5 PAGET DISEASE, JUVENILE PELIZAEUS-MERZBACHER DISEASE PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY PHENYLKETONURIA PIERSON SYNDROME PITUITARY DWARFISM III PITUITARY DWARFISM III PITUITARY DWARFISM III PITUITARY DWARFISM III PITUITARY HORMONE DEFICIENCY, COMBINED, 3; PLASMINOGEN DEFICIENCY TYPE I POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE PONTOCEREBELLAR HYPOPLASIA TYPE 2A PONTOCEREBELLAR HYPOPLASIA TYPE 4 PORPHYRIA, CONGENITAL ERYTHROPOIETIC PRECOCIOUS PUBERTY, MALE-LIMITED PRIMARY LATERAL SCLEROSIS, JUVENILE PROPERDIN DEFICIENCY, X-LINKED PROPIONIC ACIDEMIA PROPIONIC ACIDEMIA IKBKAP HAX1 PLOD1 NPC2 SMPD1 SMPD1 NPC1 NBN NDP WNT10A DCLRE1C RAG1 RAG2 MID1 TIMM8A OTC CRTAP LEPRE1 TCIRG1 CA2 CLCN7 OSTM1 TNFRSF11B PLP1 ACOX1 PAH LAMB2 HESX1 LHX3 POU1F1 PROP1 LHX3 PLG PKHD1 TSEN54 TSEN54 UROS LHCGR ALS2 CFP PCCB PCCA

13 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PYCNODYSOSTOSIS PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY PYRUVATE CARBOXYLASE DEFICIENCY PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY PYRUVATE KINASE DEFICIENCY OF RED CELLS RAINE SYNDROME RENAL-HEPATIC-PANCREATIC DYSPLASIA RENPENNING SYNDROME 1 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS RETT SYNDROME RHIZOMELIC CHONDRODYSPLASIA PUNCTATA TYPE 1 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3 RIGID SPINE MUSCULAR DYSTROPHY 1 ROBERTS SYNDROME SANDHOFF DISEASE SCHNECKENBECKEN DYSPLASIA SCID W MICROCEPHALY, GROWTH RETARDATION, & SENS TO IONIZING RADIATION SCID, AUT REC, T CELL-NEGATIVE, B CELL+, NK CELL+ SECKEL SYNDROME 1 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE SENIOR-LOKEN SYNDROME 1 SENIOR-LOKEN SYNDROME 5 SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION SEVERE COMBINED IMMUNODEFICIENCY, SEVERE COMBINED IMMUNODEFICIENCY, AUT REC, T CELL, B CELL+, NK CELL SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED SHWACHMAN-DIAMOND SYNDROME SIALURIA, FINNISH TYPE SICKLE CELL ANEMIA SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 SJOGREN-LARSSON SYNDROME SKIN FRAGILITY-WOOLLY HAIR SYNDROME SMITH-LEMLI-OPITZ SYNDROME SCNN1A SCNN1B SCNN1G SRD5A2 CTSK PNPO PC PDHX PDP1 PKLR FAM20C NPHP3 PQBP1 SFTPB SFTPC MECP2 PEX7 AGPS SEPN1 ESCO2 HEXB SLC35D1 NHEJ1 CD3D ATR TH NPHP1 IQCB1 LIG4 ADA JAK3 RAG1 RAG2 IL2RG SBDS SLC17A5 HBB GPC3 OFD1 ALDH3A2 DSP DHCR7

14 SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE SPASTIC PARAPLEGIA 2, X-LINKED SPINAL MUSCULAR ATROPHY TYPE I SPINAL MUSCULAR ATROPHY TYPE II SPINAL MUSCULAR ATROPHY TYPE III SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4 SPINAL MUSCULAR ATROPHY, X-LINKED 2 SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1 STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME STRIATONIGRAL DEGENERATION, INFANTILE STUVE-WIEDEMANN SYNDROME SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME SULFOCYSTEINURIA SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3 TAY-SACHS DISEASE T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY TETRA-AMELIA, AUTOSOMAL RECESSIVE THALASSEMIA MAJOR THROMBOTIC THROMBOCYTOPENIC PURPURA, TIGHT SKIN CONTRACTURE SYNDROME, LETHAL TRICHOTHIODYSTROPHY, PHOTOSENSITIVE TRICHOTHIODYSTROPHY, PHOTOSENSITIVE TRICHOTHIODYSTROPHY, PHOTOSENSITIVE TRIFUNCTIONAL PROTEIN DEFICIENCY TRIFUNCTIONAL PROTEIN DEFICIENCY TYROSINEMIA, TYPE I ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY Usher syndrome type 3A USHER SYNDROME, TYPE I USHER SYNDROME, TYPE IC USHER SYNDROME, TYPE ID USHER SYNDROME, TYPE IG USHER SYNDROME, TYPE IIA USHER SYNDROME, TYPE IIC VITAMIN D-DEPENDENT osteopenia, TYPE I VITAMIN D-DEPENDENT osteopenia, TYPE II VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF WAARDENBURG-SHAH SYNDROME WAARDENBURG-SHAH SYNDROME SACS PLP1 SMN1 SMN1 SMN1 IGHMBP2 PLEKHG5 UBA1 WNT7A SHROOM4 NUP62 LIFR ALDH5A1 TSPYL1 SUOX SFTPB ABCA3 HEXA FOXN1 WNT3 HBB ADAMTS13 ZMPSTE24 ERCC2 ERCC3 GTF2H5 HADHA HADHB FAH WNT7A CLRN1 MYO7A USH1C CDH23 USH1G USH2A GPR98 CYP27B1 VDR TTPA EDN3 EDNRB

15 WALKER-WARBURG SYNDROME WALKER-WARBURG SYNDROME WARBURG MICRO SYNDROME WILSON DISEASE WISKOTT-ALDRICH SYNDROME XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G X-linked Asperger syndrome-2 X-linked mental retardation X-linked mental retardation ZELLWEGER SYNDROME ZELLWEGER SYNDROME ZS POMT1 POMT2 RAB3GAP1 ATP7B WAS XPA ERCC3 XPC ERCC2 DDB2 ERCC4 ERCC5 NLGN4 NXF5 RPL10 PEX12 PEX1

All diseases on Foresight

All diseases on Foresight All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency

More information

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:

More information

CHRONIC MYELOGENOUS LEUKEMIA

CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases

More information

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions: NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4

More information

TaGSCAN v2 Gene List. Exons with reduced coverage. Estimated reduced sensitivity? OMIM # Disease Gene

TaGSCAN v2 Gene List. Exons with reduced coverage. Estimated reduced sensitivity? OMIM # Disease Gene Page 1 of 9 231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME AAAS None None 242500 ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE ABCA12 None None 610921 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3 ABCA3

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:

More information

GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate

GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate DISEASE NAME PhenoMIM GENE 1 17-alpha-hydroxylase/17,20-lyase deficiency 202110 CYP17A1 2 17-beta-hydroxysteroid dehydrogenase X

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:

More information

CLINICAL AND HUMAN TESTING

CLINICAL AND HUMAN TESTING CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with

More information

# DISEASE GENE GHI CHÚ 1 17-beta-hydroxysteroid dehydrogenase defciency, type HSD17B Hydroxy-3-methylglutaryl-CoA lyase deficiency HMGCL

# DISEASE GENE GHI CHÚ 1 17-beta-hydroxysteroid dehydrogenase defciency, type HSD17B Hydroxy-3-methylglutaryl-CoA lyase deficiency HMGCL # DISEASE GENE GHI CHÚ 1 17-beta-hydroxysteroid dehydrogenase defciency, type HSD17B3 III 2 3-Hydroxy-3-methylglutaryl-CoA lyase HMGCL 3 3-hydroxyacyl-CoA dehydrogenase defciency HADH 4 3-hydroxyisobutryl-CoA

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: EDTA Blood Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

Evolve FamilyReady Carrier Screen

Evolve FamilyReady Carrier Screen Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy

More information

Foresight Carrier Screen

Foresight Carrier Screen Freiburg Medical Laboratory, ME LLC Box 3068 Dubai, 00000 Phone: +971 4 396 2227 FE Sample Type: EDTA Blood Date of Collection: 04/23/2018 Date Received: 04/27/2018 Date Tested: 05/05/2018 Indication:

More information

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s) CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact

More information

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8 MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:

More information

Utility of Microarrays in Molecular Genetics

Utility of Microarrays in Molecular Genetics Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,

More information

COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS

COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS MITOCHONDRIAL DISORDERS NGS PANELS MITOCHONDRIAL DISORDERS NGS PANELS Name Test code Gene Name Mitome200-Nuclear 2086 (164 nuclear genes) AARS2, ACACA,

More information

CARRIER SCREEN - LIST OF DISORDERS

CARRIER SCREEN - LIST OF DISORDERS 1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase

More information

Residual risks by ethnicity

Residual risks by ethnicity Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual

More information

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function 1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency

More information

devseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders

devseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders ACSL4 Mental/retardation,/XBlinked/63 XLBR ADSL Adenylosuccinase/Deficiency AR AFF2 Mental/retardation,/XBlinked,/FRAXE/type XLBR ALG6 Congenital/disorder/of/glycosylation/type/Ic AR ANK3 Mental/retardation,/autosomal/recessive/37

More information

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non

More information

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: OG-510 Saliva Date of Collection: 07/08/2014 Date Received: 07/13/2014 Date Tested: 07/13/2014 Indication: No

More information

4978 Santa Anita Ave Temple City, CA (p) (f)

4978 Santa Anita Ave Temple City, CA (p) (f) Patient Information Doe, Jane Sex: F MR#: FD Patient#: FT-PT00000 Accession: FT-00000 Test#: FT-00000 Specimen Type: Blood (EDTA) Collection Date: Aug 01, 2017 Partner Information Not Tested Accession:

More information

HERES Carrier Screening TEST

HERES Carrier Screening TEST LISTADO DE ENFERMEDADES ANALIZADAS HERES Carrier Screening TEST 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha-Hydroxylase Deficiency 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency

More information

About PrenatalScreen Prenatal Test

About PrenatalScreen Prenatal Test About PrenatalScreen Prenatal Test PrenatalScreen Prenatal Test is a genetic test that analyses fetal DNA, obtained from CVS or amniotic fluid following an invasive prenatal diagnosis, to screen for monogenic

More information

Table 1: PrenatalScreen - List of analysed genes and examined genetic diseases

Table 1: PrenatalScreen - List of analysed genes and examined genetic diseases Table 1: PrenatalScreen - List of analysed genes and examined genetic diseases DISEASE PhenoMIM GENE 1 17-alpha-hydroxylase/17,20-lyase deficiency 202110 CYP17A1 2 17-beta-hydroxysteroid dehydrogenase

More information

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate MALATTIA PhenoMIM GENE 1 17-alpha-hydroxylase/17,20-lyase deficiency 202110 CYP17A1 2 17-beta-hydroxysteroid

More information

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR

More information

Subject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained:

Subject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained: TEST PERFORMED Whole exome sequencing (WES) with Focused Diagnostic Panel(s): Neuropathy, Leukodystrophy, Myopathy See below for a complete list of genes analyzed. RESULTS 1 sequence variant with potential

More information

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels Targeted s and Methodology Details for Epilepsy/Seizure tic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Epilepsy/Seizure tic Panels Epilepsy Expanded Panel Epilepsy Expanded

More information

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS A broad menu covering the vast majority of inherited metabolic disorders that are routinely tested as part of state newborn screening

More information

CARRIER SCREENING PANEL

CARRIER SCREENING PANEL 1 / 6 1. WHAT IS THE CARRIER? The carrier screening panel is a genetic test that simultaneously analyses mutations in 298 genes which cause recessive inherited pathologies. Diseases with a recessive inheritance

More information

Newborn Genetic Analysis

Newborn Genetic Analysis Fulgent tics Newborn tic Analysis Newborn tic Analysis (NGA) is a highly sophisticated and sensitive genetic test that identifies DNA changes that can cause infants to develop severe or life-altering conditions.

More information

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List Recombine 2 CarrierMap 4 Genetic Counseling TABLE OF CONTENTS 8 12 14 Technology Sample Report New Offerings 18 Recombine Facts 19 Disease List CARRIERMA ROVIDES COMLETE We help families have healthy children

More information

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary Results Recipient University Medical Center 827 Attn: Dr. Paul Smith 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 NPI: 7834324983 Report Date: 09/09/2013 Female Ethnicity:

More information

Inherited Leukoencephalopathies

Inherited Leukoencephalopathies 3 Inherited Leukoencephalopathies Deborah L. Renaud, M.D. 1 1 Departments of Neurology and Pediatrics, Mayo Clinic, Rochester, Minnesota Semin Neurol 2012;32:3 8. Leukoencephalopathies are conditions that

More information

LABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS

LABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS LABHORIZONS A NEWSLETTER FOR CLIENTS Volume XVII, No. 7 July 2017 New Procedures 5 HIAA, Plasma.................................. 504510 CPT 83497 Synonyms 5-hydroxyindoleacetic acid Use Plasma 5-hydroxy-indoleacetic

More information

Results Recipient Ordering Healthcare Professional Male Details Female Details

Results Recipient Ordering Healthcare Professional Male Details Female Details Results Recipient Ordering Healthcare Professional Male Details Details Report Date /2010 Attn: Jessica Jacobson, MD Counsyl, Inc. 2200 Bridge Parkway, Suite 103 Redwood City, CA 94065 Phone: 1-888-COUNSYL

More information

PITTSBURGH CYTOGENETICS LABORATORY

PITTSBURGH CYTOGENETICS LABORATORY PITTSBURGH CYTOGENETICS LABORATORY GENES COVERED BY X-HR AND SYNDROMES DETECTED BY X-HR # GENES LOCI DISORDERS 1 ABCB7 Xq12-q13 Anemia, sideroblastic, with ataxia 2 ABCD1 Xq28 Adrenoleukodystrophy 3 ACSL4

More information

רשימת המחלות הנסקרות בבדיקה

רשימת המחלות הנסקרות בבדיקה רשימת המחלות הנסקרות בבדיקה By סקר גנטי טרום הריון - FamilyFirst בדיקת סקר גנטי טרום הריוני מורחב, הסוקרת כ- 850 מוטציות העלולות לחולל 255 מחלות תורשתיות. הבדיקה כוללת את כל המחלות המומלצות ע"י משרד הבריאות

More information

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018 Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive

More information

PRICE AND TEST LIST January 4, 2018 (by Test Code)

PRICE AND TEST LIST January 4, 2018 (by Test Code) Test Code Test Description TAT Price 2018 CPT Codes WHOLE EXOME SEQUENCING WES001 MNG Exome TM Trio Sequencing and Copy Number Analysis + mtdna (Proband + 2 Family Members) 2-4 Weeks $6,900.00 81415, 81416,

More information

PREDICAGEN LLC REPORT

PREDICAGEN LLC REPORT The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because

More information

Expanded carrier screening for monogenic disorders: where are we now?

Expanded carrier screening for monogenic disorders: where are we now? DOI: 10.1002/pd.5109 SPECIAL TOPIC ISSUE ON ADVANCES IN THE DIAGNOSIS OF SINGLE GENE DISORDERS Expanded carrier screening for monogenic disorders: where are we now? Davit Chokoshvili*, Danya Vears and

More information

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10

More information

PGD: A Celebration of 20 years:

PGD: A Celebration of 20 years: PGD: A Celebration of 20 years: What is Reality and What is Not? Roma June 30, 2010 Mark Hughes, M.D., Ph.D. Professor of Genetics, Internal Medicine, Pathology Director, Genesis Genetics Institute Director,

More information

Standard Therapies - Cord Blood

Standard Therapies - Cord Blood A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical

More information

Strand Neuromuscular Disorders Test: Genes & Test Selection

Strand Neuromuscular Disorders Test: Genes & Test Selection 1 Strand Neuromuscular Disorders Test: Genes & Test Selection 2 Can the Strand Neuromuscular Disorders Test Be Offered for Prenatal Diagnosis? 3 Strand Neuromuscular Disorders Test: Genes & Test Selection

More information

devact TM Clinical Management Panel for Neurodevelopmental Disorders

devact TM Clinical Management Panel for Neurodevelopmental Disorders Amino acid disorder AMT Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GCSH Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GLDC Glycine encephalopathy

More information

Whole exome sequencing Gene package Epilepsy version 1,

Whole exome sequencing Gene package Epilepsy version 1, Whole Exome Sequencing Gene package Epilepsy, version 1, 8 4 2015 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations

Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations Sema4 Natalis Clinical significance of panel Sema4 has designed and validated Natalis, a supplemental newborn screening panel offered for newborns, infants, and young children. This test may be offered

More information

HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS

HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS ACQUIRED ANEMIAS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are

More information

PRICE AND TEST LIST August 24, 2018 (by Test Code)

PRICE AND TEST LIST August 24, 2018 (by Test Code) Test Code Test Description TAT Price 2018 CPT Codes WHOLE GENOME SEQUENCING WGS001 MNGenome TRIO Sequencing 2-6 Weeks Call 81425, 81426 x2 WGS003 MNGenome Proband Only Sequencing 2-6 Weeks Call 81425 WHOLE

More information

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child

More information

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

Diagnose a broad range of metabolic disorders with a single test, Global MAPS PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds

More information

The Counsyl Foresight Carrier Screen

The Counsyl Foresight Carrier Screen The Counsyl Foresight Carrier Screen 180 Kimball Way South San Francisco, CA 94080 www.counsyl.com contact@counsyl.com (888) COUNSYL The Counsyl Foresight Carrier Screen - Disease Reference Book 11-beta-hydroxylase-deficient

More information

Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS

Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS UNIVERSITY OF MINNESOTA PHYSICIANS OUTREACH LABS MOLECULAR DIAGNOSTICS (612) 273-8445 DATE: TIME COLLECTED: AM PM PCU/CLINIC: DIAGNOSIS (Dx) / DIAGNOSIS CODES (ICD-9) - OUTPATIENTS ONLY (1) (2) SPECIMEN

More information

GENE BY GENE CARRIER SCREENING

GENE BY GENE CARRIER SCREENING Patient Copy GENE BY GENE CARRIER SCREENING GENE BY GENE CARRIER SCREEN Various genetic mutations occur with increased frequencies in various ethnic groups in the United States and around the world. For

More information

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro

More information

Knowledge is power. Plan ahead with GeneAware.

Knowledge is power. Plan ahead with GeneAware. MATERNAL FETAL Many patients may have questions regarding specific genetic disorders that may arise when planning or expecting a baby. That s why Baylor Genetics developed GeneAware, a reproductive carrier

More information

FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY # Colorectal cancer, hereditary nonpolyposis # Meckel syndrome, type 1 #249000

FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY # Colorectal cancer, hereditary nonpolyposis # Meckel syndrome, type 1 #249000 Supplementary Table 1 A randomly selected subset of 100 record pairs crossreferenced by the curators. To be sure the 7,000 cross referenced records in fact were pairs of highly overlapping phenotypes,

More information

BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related

BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related Geni investigati e patologie associate BabyNEXT TM EXTENDED Gene Disease OMIM gene ABCC8 Familial hyperinsulinism ABCC8-related OMIM Disease Condition 600509 256450 Metabolic disorder - ABCD1 Adrenoleukodystrophy

More information

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Coincide nce Expected coincidence Maximum possible comorbidity Disease1 Disease2 Link(KEGG)

More information

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro

More information

CilioPathy panel. 3-Jul-2018 (102 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID

CilioPathy panel. 3-Jul-2018 (102 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID versie 3-Jul-2018 (102 genen) CilioPathy panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern AHI1 608894 Joubert

More information

Further expansion of the neonatal screening panel in the Netherlands

Further expansion of the neonatal screening panel in the Netherlands Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1

More information

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of

More information

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017 Tests and Profiles Tests Method Sample Needed TAT Genetic Consultation / - All samples to be sent at 2 8 C. Counseling 1 Urine MRST - 15 ml Urine 24 hrs 2 Sr. Ammonia, Lactate, Sugar Fuji Dry Chem 2 ml

More information

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National

More information

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016.

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016. CENTOGENE Report: cases of rare diseases at CENTOGENE January 202 to June 206 Elucidating the basis for the link between the clinical phenotype and genotype correlation, and the factors contributing to

More information

cataract panel 16-Apr-2018 (63 genen) Centrum voor Medische Genetica Gent versie OMIM gene ID

cataract panel 16-Apr-2018 (63 genen) Centrum voor Medische Genetica Gent versie OMIM gene ID versie 16-Apr-2018 (63 genen) cataract panel Centrum voor Medische Genetica Gent Gene OMIM gene ID AGK 610345 ALDH18A1 138250 Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance

More information

Requisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection:

Requisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection: Reason for Referral: Diagnostic Testing: Affected Unaffected Carrier testing/known Family Mutation Name of index case in the family (include copy of report): Date of Birth: Relationship to this patient:

More information

Bewegingsstoornisssen genpanel v1 (203 genen)

Bewegingsstoornisssen genpanel v1 (203 genen) Bewegingsstoornisssen genpanel v1 (203 genen) ABCB7 99,8 Anemia, sideroblastic, with ataxia, 301310 ABCD1 98,7 Adrenoleukodystrophy, 300100 Adrenomyeloneuropathy, adult, 300100 ABHD12 93,8 Polyneuropathy,

More information

General Test Requisition Form - Biochemical and Molecular

General Test Requisition Form - Biochemical and Molecular General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name MM/ DD

More information

General Test Requisition Form - Biochemical and Molecular

General Test Requisition Form - Biochemical and Molecular General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name Middle

More information

Dysmorphology Guy Besley

Dysmorphology Guy Besley Dysmorphology Guy Besley Willink Biochemical Genetics Unit, Manchester Children s s Hospital Dysmorphic presentation Congenital malformation Disorder of embryogenesis Intrauterine insult infection; chromosomal/genetic

More information

Whole exome sequencing Gene package Epilepsy version 3,

Whole exome sequencing Gene package Epilepsy version 3, Whole Exome Sequencing Gene package Epilepsy, version 3, 1 2 2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced on the Illumina

More information

Request for expedited Result

Request for expedited Result London Health Sciences Centre Molecular Genetics Laboratories Requisition for DNA Testing DACC002 REV 20170815 AUTHORIZED SIGNATURE IS REQUIRED INCOMPLETE REQUESTS WILL BE BANKED Molecular Genetics Laboratory

More information

Survey of prenatal testing for genetic disorders in Japan: Recent report

Survey of prenatal testing for genetic disorders in Japan: Recent report doi:10.1111/jog.12948 J. Obstet. Gynaecol. Res. Vol. 42, No. 4: 375 379, April 2016 Survey of prenatal testing for genetic disorders in Japan: Recent report Takahiro Nobuzane 1, Takahiro Yamada 2,KiyonoriMiura

More information

For Your Baby s Health Department of Health

For Your Baby s Health Department of Health Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your

More information

MetBioNet Best Practice Guidelines. Investigation of an inherited metabolic cause of cardiomyopathy

MetBioNet Best Practice Guidelines. Investigation of an inherited metabolic cause of cardiomyopathy Introduction MetBioNet Best Practice Guidelines Investigation of an inherited metabolic cause of Inborn errors of metabolism (IEM) account for at least 5% of cases of. In some disorders, is the major cause

More information

'Translating massively parallel sequencing into clinical diagnostics.

'Translating massively parallel sequencing into clinical diagnostics. 'Translating massively parallel sequencing into clinical diagnostics. SA Pathology at the Women s and and The University of Adelaide Adelaide, Australia MPS is revolutionising genetics & biology - >100

More information

Whole exome sequencing Gene package Epilepsy version 2,

Whole exome sequencing Gene package Epilepsy version 2, Whole Exome Sequencing Gene package Epilepsy, version 2, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Centers for Medicare and Medicaid Services

Centers for Medicare and Medicaid Services Centers for Medicare and Medicaid Services Clinical Laboratory Fee Schedule Annual Laboratory Public Meeting June 25, 2018 Anthony Sireci, MD, Msc Association for Molecular Pathology Outline Germline Procedures

More information

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search

More information

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics SESSION 7 Medical Genetics Hemoglobinopathies and Biochemical Genetics J a v a d F a s a J a m s h i d i U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 Hemoglobinopathies

More information

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management

More information

What s New in Newborn Screening?

What s New in Newborn Screening? What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is mandated and administered by the Illinois Department of

More information

Next-generation sequencing-based molecular diagnosis of neonatal hypotonia in Chinese

Next-generation sequencing-based molecular diagnosis of neonatal hypotonia in Chinese Title page Next-generation sequencing-based molecular diagnosis of neonatal hypotonia in Chinese Population Yan Wang 1, #,Wei peng 1,#, Hong-Yan Guo 3,4, Hui Li 3,4, Jie Tian 3,4, Yu-Jing Shi 3,4, Xiao

More information

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine

More information

Newborn Screening: Focus on Treatment

Newborn Screening: Focus on Treatment Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public

More information

The University of Chicago Genetic Services Laboratories

The University of Chicago Genetic Services Laboratories Aceruloplasminemia testing CP sequencing Aceruloplasminemia CP deletion/duplication Albinism testing Albinism Sequencing Panel (20 genes Albinism Deletion/Duplication Panel (20 genes Alstrom syndrome testing

More information

Genetics in Nephrology. Saeid Morovvati Associate Professor of BMSU Director of Biogene Laboratory

Genetics in Nephrology. Saeid Morovvati Associate Professor of BMSU Director of Biogene Laboratory Genetics in Nephrology Saeid Morovvati Associate Professor of BMSU Director of Biogene Laboratory Genetics in: A. Congenital Anomalies of the Kidney and Urinary Tract B. Cystic Diseases of the Kidney C.

More information

Sperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic

Sperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic Sperm Donor Profile This packet is for informational purposes. All the questions have been answered by the donor and are unaltered with exception to the staff impressions, genetic screening results, and

More information

Reproductive Physiology Primordial Germ Cells Yolk Sac Sex Chromosomes Females Males Sex-Linked Traits

Reproductive Physiology Primordial Germ Cells Yolk Sac Sex Chromosomes Females Males Sex-Linked Traits Reproductive Physiology Primordial Germ Cells - from Yolk Sac these migrate to fetus when it is 5 weeks old - these cells give rise to the gonads (ovaries for female, testes for male) first they form the

More information